Blogs
Healthcare and Medtech Research Reports
Oct 20, 2026
Nouscom Secures Major Series D Funding and Prepares to Share Long-Term Clinical Findings in Lynch Syndrome Carriers at ESMO Nouscom has announced the completion of an oversubscribed €120 million ($135 million) Series D financing round. The investment was co-led by M Ventures and Revelation Partners, with partici...
Read More...
Jul 29, 2022
Key Highlights The US approval of Jynarque added the much-needed push to the ADPKD treatment market.In the coming years, Bardoxolone methyl is expected to be an effective therapy for ADPKD treatment.The current ADPKD treatment only aims to delay the disease progression rather than completely cure the disease, wh...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper